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ABSTRACT: Cysteine redox state has been identified as one of the key biological influences behind protein structure and/or 
function. Altered protein redox state has been shown to cause significant physiological changes and can leave proteins with 
changed sensitivity to oxidative stress.  Protein redox state changes are recognized as an important mediator of disease, cellular 
abnormalities or environmental changes and therefore their characterization is of interest.  Isotopic or isobaric labeling followed by 
sample multiplexing and analysis by liquid chromatography tandem mass spectrometry (LC-MS/MS) allows relative comparison of 
protein expression levels or of protein redox state between several samples.  Combining analysis of protein expression level and 
redox state into one analysis would add an extra dimension and permit the normalization of protein redox changes with protein 
abundance.  To achieve this, we have developed a quantitation workflow that uses commercially available cysteine-reactive tandem 
mass tags (iodoTMT) to differentially label cysteine residues, and applied it to two Leishmania mexicana cell-lines that have 
previously shown different responses to oxidative stress.  The individually labeled samples have been pooled in different 
combinations to create multiple sixplex samples in order to study the relationship between cysteine oxidation and overall protein 
expression, as well as providing information about protein oxidation levels in each cell-line.  The results highlight eleven proteins 
that are differentially expressed between the two cell-lines and/or have significant redox changes.  This advanced multiplexing 
method effectively demonstrates the flexibility of tandem mass tags and how they can be used to maximize the amount of 
information that can be acquired.       
Cysteine residues play an important role in the structure and 
function of proteins because they are sensitive to oxidation or 
reduction.  Free (reduced) cysteines (SH) are highly reactive 
and can form reversible or irreversible modifications such as 
disulfide bonds (S-S), nitrosylations (SNO), sulfenylations 
(SOH) and sulfonylations (SO3H).
1-2
  Reversible cysteine 
modifications can act as a biological switch, activating or 
deactivating biological processes depending on the cysteine 
redox state.  Disulfide bonds can be involved in stabilizing 
protein tertiary and quaternary conformations, which in turn 
can influence the stability and function of the protein.
3
  
Cysteine modifications are mediated by changes in redox state 
and provide a link between oxidative stress and pathologies 
such as cardiovascular disease, diabetes, neurodegenerative 
diseases and others.
4-8
  
Comparative proteomic analyses, which allow protein 
expression changes to be linked to phenotype, are typically 
performed under reducing conditions and are thus insensitive 
to reversible oxidative changes.  Several proteomic approaches 
have been developed to assess differences in cysteine 
oxidation under conditions of interest (reviewed by Chouchani 
et al., 2011; Murray & Van Eyk, 2012; Wojdyla & Rogowska-
Wrzesinska, 2015).
2, 9-10
  These methods involve selective or 
differential labeling of modified and unmodified cysteine 
residues with the aim of capturing cysteine redox state under 
physiological conditions.  Isotopic labeling allows co-elution 
of differentially labeled peptides in liquid chromatography 
(LC) coupled with mass spectrometry (MS) to resolve labels 
with distinct masses,
10-12
 which permits relative quantitation 
by comparing the ratio between the light-labeled and the 
heavy-labeled peptides.
13-14
  Issues may arise with isotopic 
labeling if the two labels are chemically distinct, as labeled 
peptides may not completely co-elute.  In addition, the 
resulting mass spectrum becomes twice as complicated due to 
multiple peaks corresponding to the same peptide.
15
  In order 
to overcome these difficulties, isobaric labels have been 
created that are chemically and structurally identical, however 
the placement of the heavy isotopes (
13
C and 
15
N) varies in 
each label.  Through tandem mass spectrometry (MS/MS), 
these labels are engineered to break at a specific bond, 
creating a reporter ion that will differ in mass for each isobaric 
tag and allowing direct comparisons to be made between 
multiple samples in a single run.
15-16
  
Tandem Mass Tags (TMT) are isobaric reagents that are 
available with different reactive groups depending on the 
labeling required.  Amine-reactive TMTs are typically used to 
label tryptic peptides, reacting with lysines and peptide N-
terminal amines to give relative quantitation for the overall 
protein concentration changes between samples.  Iodoacetyl 
Tandem Mass Tags (iodoTMT) have been designed to react 
irreversibly with reduced cysteine residues through the 
iodoacetyl group (see Supplementary Information) and can 
therefore be used to study cysteine oxidation status.
17-18
  The 
iodoTMT reagent set is available as a sixplex, which allows up 
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Figure 1. Schematic of the sample workflow. (a) One half of each sample is reduced fully and all cysteines are labeled with iodoTMT, 
while the other half is treated with NEM to block all free cysteines (SH) and subsequently any modified cysteines are reduced and labeled 
with iodoTMT. (b) For this study, three replicates for each cell-line (wild-type & H-line) have been cultured and treated using the 
workflow shown in part (a).  Individually labeled samples have then been combined to create four sixplex samples in order to determine 
relative change in protein expression, relative change in cysteine oxidation and percentage oxidation for each cell-line. 
 
to six samples to be directly compared and quantified.  Given 
the relative rarity of naturally-occurring cysteine residues, 
cysteine-containing peptides tend to be a relatively small 
proportion of the total peptide content, therefore an anti-TMT 
antibody resin can be used to selectively bind and enrich 
TMT-labeled peptides in order to improve the detection and 
identification of these peptides.  
In addition to simply reducing and labeling all cysteine 
residues, cysteine-reactive reagents have been applied in more 
complex methods to investigate and quantify specific types of 
cysteine modifications or to relate cysteine oxidation with 
other protein changes.
2, 10
  Qu et al. selectively reduced 
nitrosylated cysteines using sodium ascorbate prior to 
iodoTMT labeling to measure the effects of nitric oxide 
signaling, while Pan et al. included sequential iodoTMT 
labeling steps to compare the level of nitrosylated cysteines to 
the level of the remaining reversible cysteine modifications 
across multiple samples.
19-20
  Van der Reest et al. utilized 
stable isotope labeling to quantify oxidation changes by 
reacting reduced cysteines with light/heavy iodoacetamide, 
while also using light/heavy dimethyl labeling to quantify 
protein expression changes.
21
  In a similar vein, Shakir et al. 
have discussed a method for using iodoTMT to quantify 
changes in percentage oxidation through comparisons between 
oxidized samples and fully reduced samples.
22
   
Building upon these previous studies, we have designed a 
workflow that uses iodoTMT multiplexing and mix-and-match 
sample assembly in order to normalize changes in cysteine 
oxidation levels with respect to changes in overall protein 
expression, allowing quantitative comparison of protein 
oxidation (see Figure 1).  We have applied this workflow to 
compare isogenic lines of the protozoan parasite Leishmania 
mexicana that display contrasting virulence phenotypes.   
Leishmaniasis is an important human and canine disease, for 
which no vaccine is available.  We have previously shown that 
selection of Leishmania mexicana with the aminoglycoside 
antibiotic gentamicin results in stable attenuation of virulence, 
a phenotype that we are currently investigating for potential as 
a vaccine to control leishmaniasis.
23
  Comparative proteomic 
analyses have shown that the attenuated line has a greater 
susceptibility to oxidative stress
24
 compared with the virulent 
wild-type, and we therefore wished to investigate proteins that 
show significant changes in redox state that could be a 
potential target for drug treatment.   
MATERIALS 
N-Ethylmaleimide (NEM), Tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP-HCl), Pierce™ Detergent Compatible 
Bradford Assay, iodoTMTsixplex™ Isobaric Reagent Set, 
Immobilized Anti-TMT™ Antibody Resin, TMT™ Elution 
Buffer, Pierce™ Spin Columns – Screw Cap, Pierce™ 
Quantitative Colorimetric Peptide Assay [Thermo Scientific], 
Acetone, Tris(hydroxymethyl)aminomethane (Tris), 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), 
Ethylenediaminetetraacetic acid (EDTA) [Fisher Scientific], 
Acetonitrile (MeCN), Methanol (MeOH) [Rathburn 
Chemicals], Neocuproine, Dithiothreitol (DTT), Formic Acid, 
Sodium Dodecyl Sulfate (SDS), Trypsin [Promega], FASP 
protein digestion kit [Expedeon], Sodium Chloride (NaCl) 
[VWR], Haemoflagellate Minimal Essential Medium 
(HOMEM), Heat Inactivated Fetal Bovine Serum (HI-FBS), 
Streptomycin, Penicillin [Gibco]. 
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Figure 2.  Labeling workflow for wild-type (WT) and H-line (H) cell-lines of Leishmania mexicana. (a) Each sample was split into two 
equal parts and either fully reduced (-red) or blocked with NEM (-ox) before iodoTMT labeling. (b) By using strategic iodoTMT labeling, 
the individually labeled samples could then be combined in different groups to create four sixplex samples, providing relative quantitation 
for protein expression (Red), quantitation of cysteine oxidation (Ox), percentage of cysteine oxidation in wild-type (W) and percentage of 
cysteine oxidation in H-line (H). 
 
EXPERIMENTAL 
Cell Cultures.  Wild-Type (WT) Leishmania mexicana 
strain M379 promastigotes were selected in the presence of 
gentamicin to generate an attenuated line (H), as previously 
reported by Daneshvar et al.
25
   
Three biological replicates each of WT and H-line were 
cultured in complete HOMEM (6 samples in total) with 
10%HI-FBS at 25 °C and sub-passaged every 2-3 days.  Each 
replicate was split into two equal aliquots of approximately 
5x10
7
 cells (12 samples in total) and centrifuged at 1,000 x g 
for 10 mins.  Samples were washed twice to remove salts and 
other soluble macromolecules, by resuspension in cold PBS, 
followed by centrifugation at 1,000 x g for 10 mins.  
Cell Lysis.  One sample from each culture was resuspended 
in 200 µL of SDT lysis buffer (4% SDS, 100 mM Tris base 
and 0.1 M DTT, pH 7.6).  The remaining six samples were 
resuspended in 200 µL NEM lysis buffer (250 mM HEPES, 10 
mM EDTA, 0.1 mM Neocuproine, 2% SDS and 100 mM 
NEM, pH 7.0)
2, 26
  Samples in NEM buffer were incubated at 
37 °C in the dark for 90 mins with gentle mixing to allow the 
NEM to react irreversibly with free thiols.  
Cells were lysed by probe sonication, alternating a 2 second 
pulse with 1 minute cooling on ice ten times.  Samples were 
then centrifuged for 10 mins at 13,000 x g to remove cell 
debris and other insoluble material.  The supernatant was 
removed into separate eppendorfs and ice-cold acetone (4x 
sample volume) was added to each sample, vortexed briefly 
and then stored at -20 °C overnight.  Samples were centrifuged 
for 10 mins at 13,000 x g at 4 °C and the supernatant was 
carefully removed.  The protein pellet was washed twice with 
80% ice-cold acetone, vortexed briefly and then centrifuged to 
remove the supernatant.  Protein pellets were stored at -20 °C 
until required.     
Isobaric Labeling.  Protein pellets were resuspended in 
HEPES buffer (50 mM HEPES, 1 mM EDTA, 0.1 % SDS, pH 
8.0) and the protein concentration was measured using a 
Bradford Assay.  Each sample was split into two 30 µg 
aliquots (24 samples in total) and made up to equal volumes 
with HEPES buffer.  Reduction of reversibly modified 
cysteine residues was performed using TCEP-HCl (final 
concentration ~5 mM), then samples were vortexed briefly to 
mix and incubated at 37 °C for 1 hour.  Irreversibly modified 
cysteines, such as sulfonylations, are unaffected by TCEP 
reduction and therefore cannot be quantified using this 
method. 
IodoTMT reagents were resuspended in MeOH to a 
concentration of 10 mg mL
-1
 and samples were labeled with 
10 µL of the appropriate iodoTMT reagent, as described in 
Figure 2.  Samples were incubated at 37 °C in the dark for 1 
hour, before being quenched with DTT (final concentration of 
~20 mM) and incubated for a further 15 mins at  37 °C in the 
dark. 
Individual samples were combined in equal protein 
concentrations into four sixplex samples; a fully-reduced 
(Red) sample with all cysteines labeled with iodoTMT, an 
NEM-blocked (Ox) sample with only modified cysteines 
labeled with iodoTMT, and wild-type (W) and H-line (H) only 
samples comparing modified cysteines with total cysteine 
content for each cell-line, as described in Figure 2.  
Enzymatic digestion was carried out using the FASP protein 
digestion kit, digesting samples overnight at 37 °C with 
trypsin.  
Affinity Purification.  Peptide samples were dried in a 
SpeedVac before being reconstituted in 200 µL TBS Buffer 
(25 mM Tris, 0.15M NaCl, pH 7.2).  Affinity purification was 
carried out using 400 µL anti-TMT slurry in a spin column, 
following manufacturer’s instructions, including an incubation  
NEM reduce iodoTMTiodoTMT reduce
WT1ox
WT2ox
WT3ox
H1ox
H2ox
H3ox
126
127
128
129
130
131
label
WT1red 129
WT2red 130
WT3red 131
H1red 126
H2red 127
H3red 128
label
WT1
WT2
WT3
H1
H2
H3
Samples(a)
W
WT1ox 126
WT2ox 127
WT3ox 128
WT1red 129
WT2red 130
WT3red 131
Ox
WT1ox 126
WT2ox 127
WT3ox 128
H1ox 129
H2ox 130
H3ox 131
H1red 126
H2red 127
H3red 128
WT1red 129
WT2red 130
WT3red 131
Red H
H1red 126
H2red 127
H3red 128
H1ox 129
H2ox 130
H3ox 131
(b)
4 
 
Figure 3.  The equations used to calculate quantitation ratios for each sample using the average reporter ion abundances for each group of 
three replicates, along with the significance of the resulting ratios. 
 
step at 4 °C overnight with end-over-end mixing.  Unbound 
peptides were washed from the column using 5x column 
volumes of TBS buffer followed by 3x column volumes of 
water.  The labeled peptides were eluted from the column 
using 4x column volumes of TMT elution buffer.  All eluted 
fractions (labeled and unlabeled peptides) were dried in the 
SpeedVac and reconstituted in 10% MeCN + 0.1% formic 
acid.  Approximately 6 µg of each sample was pipetted into a 
96-well microplate, dried in the SpeedVac and stored at -20 °C 
until ready for analysis.   
LC-MS/MS Analysis.  Analysis was carried out by LC-
MS/MS using an Ultimate 3000 RSLCnano liquid 
chromatography (nanoLC) system [Dionex] and an LTQ-
Orbitrap Elite mass spectrometer [Thermo Scientific] with 
nanospray ionization (NSI). A C18 trap column (5 mm x 300 
µm ID, 5 µm, 100 Å) and Acclaim PepMap 100 C18 column 
(150 mm x 75 µm ID, 3 µm, 100 Å) [Thermo Scientific] were 
used for chromatography.  
Peptides were reconstituted in 10 µL loading buffer (1% 
MeCN + 0.05% formic acid (v/v)) and injected onto the trap 
column for 4 mins using a loading buffer solvent flow rate of 
25 µL min
-1
.  Peptides were then transferred to the analytical 
column using starting chromatographic conditions; 95% 
Buffer A (Water + 0.1% formic acid) / 5% Buffer B (80 % 
MeCN + 0.08% formic acid) (v/v).  A 150 minute gradient 
was used, 5% B – 45% B (v/v), with a solvent flow rate of 300 
nL min
-1
, followed by a wash step of 100% B for 6 mins and 
then re-equilibration at starting solvent conditions for 5 mins, 
for a total run time of 165 mins. 
The LTQ-Orbitrap Elite acquired a high resolution MS scan 
(resolving power 60,000 at m/z 400) over a mass range of m/z 
380 – 1800 in positive mode.  A maximum ion injection time 
of 200 ms was allowed for Orbitrap analyses, with an AGC 
target of 1x10
6
.  The three most abundant multiply charged 
ions in the MS scan above the set signal thresholds were then 
selected for consecutive MS/MS analyses by Higher-energy 
Collisional Dissociation (HCD) and Collision Induced 
Dissociation (CID).  Precursor ions were isolated in the LTQ 
ion trap using an isolation window of m/z 1.2, a maximum ion 
injection time of 25 ms and an AGC target of 3x10
4
.  HCD 
fragmentation was performed in the HCD collision cell using 
helium as a collision gas and detected in the Orbitrap using the 
following parameters; signal threshold: 1000, collision energy 
(CE): 50, stepped CE width: 10%, number of CE steps: 2, 
activation time: 0.1 ms, resolving power: 15,000 at m/z 400.  
CID was performed in the LTQ ion trap employing helium as 
a collision gas, using the following parameters; signal 
threshold: 500, CE: 35, stepped CE width: 10%, number of CE 
steps: 2, activation time: 10 ms, activation Q: 0.250.  After 30 
seconds, selected precursor ions were added to an exclusion 
list for a further 180 seconds to avoid repeated analyses of 
highly abundant ions at the expense of lower abundance ions.   
Data Processing.  Data processing was carried out in 
Proteome Discoverer™ software version 2.1 SP1 [Thermo 
Fisher Scientific] using Mascot version 2.6.1 [Matrix Science] 
for database searching.  MS/MS spectra were searched against 
the LmexicanaMHOMGT2001U1103 database (version 32, 
16
th
 April 2017) using the following parameters; enzyme: 
Trypsin (full), maximum missed cleavages: 2, precursor mass 
tolerance: 10 ppm, fragment mass tolerance: 0.6 Da, 
quantitation method: iodoTMT 6plex, reporter ion integration 
tolerance: 20 ppm, isolation interference threshold: 20%.  
Variable modifications included oxidation (M), iodoTMT (C), 
N-ethylmaleimide (C), N-ethylmaleimide+water (C/K) and 
Protein N-terminal acetylation.  Protein quantitation was 
calculated using unique peptides only, and peptides with 
missing quantitation channels were excluded from 
quantitation.  Peptides were filtered with a 5% FDR cutoff, 
with all peptides above 1% FDR given a high confidence 
rating.  Reporter ion abundances were calculated using the 
signal-to-noise ratios from the reporter peaks each HCD 
spectrum, or from the ion intensities when using ion trap CID 
data, and then scaled so that each protein can be compared 
directly.  Isotopic correction has been applied using the values 
provided with the iodoTMT reagents.  
RESULTS AND DISCUSSION 
The purpose of this experiment was to identify protein 
oxidative changes between two Leishmania mexicana cell-
lines, and to normalize these changes with respect to changes 
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Figure 4. Reporter ion spectra for peptide CQDATGNTYIATDNICPFADFER (LmxM.36.2570) from samples Red, Ox, H and W 
(clockwise from top left).  The average of each group of replicates is denoted by the dashed lines, with the calculated standard deviation 
displayed by the surrounding colored box.  Quantitation ratios for each sample have been calculated from the replicate averages, where the 
blue group corresponds to the denominator (see Table 1).  Peaks that do not correspond to the iodoTMT reporter ions have been labeled in 
grey. 
Table 1. Quantitation ratios have been calculated for peptide CQDATGNTYIATDNICPFADFER (LmxM.36.2570) from 
each sample. Where multiple MS/MS spectra have been acquired, the table displays the average quantitation ratio from all 
available reporter ion spectra.  The change in oxidation has been calculated using both equations from Equation 1.  Both 
cysteines have been labeled with iodoTMT. 
Accession Protein Peptide Sequence Red Ox W H 
Ox
Red
 
H
W
 
LmxM.36.2570 
membrane-bound acid 
phosphatase precursor 
CQDATGNTYIATD
NICPFADFER 
0.891 0.929 0.118 0.112 1.043 0.949 
 
in protein expression.  Three biological replicates of each cell-
line, virulent wild-type (WT) and attenuated H-line (H), were 
grown and each culture was divided and treated separately to 
create two different sample sets (see Figures 1 and 2).  One 
half of each sample was incubated with N-ethylmaleimide 
during cell lysis to irreversibly block any free cysteines (SH) 
and prevent any further redox reactions.  Any reversibly 
modified cysteines were then reduced and labeled with 
iodoTMT reagents.  In order to quantify protein expression 
levels for cysteine-containing proteins, the other half of each 
sample was fully reduced and all cysteine residues were 
labeled with iodoTMT.  Affinity purification using an anti-
TMT antibody was carried out after trypsin digestion, 
allowing unlabeled peptides to be depleted while enriching for 
the iodoTMT-labeled peptides prior to MS analysis.    
Relative quantitation for each sample has been calculated 
from the average reporter ion abundances from each group of 
three replicates, as shown in the equations in Figure 3, 
investigating H-line abundance in relation to wild-type (Red & 
Ox) or quantifying oxidized cysteines as a proportion of total 
cysteine content (W & H).  The resulting ratios can be used to 
quantify changes in protein expression (Red), changes in 
oxidation levels (Ox) and the percentage oxidation level for 
proteins in each cell-line (W & H) as explained in the table in 
Figure 3.  
A ratio of 1 calculated for a protein in sample Red or Ox 
would suggest no change in protein expression or cysteine 
oxidation between H-line and wild-type, while a ratio of 0.5 
would indicate a 50% decrease in the H-line sample.  Ratios 
calculated for samples W and H represent the percentage 
oxidation for each cell-line, where the maximum ratio of 1 
would signify 100% oxidation. 
The normalized change in oxidation ratio can be calculated 
in two ways, as shown in Equation 1, either by normalizing 
the oxidized sample (Ox) by the fully-reduced sample (Red) or 
by normalizing the H-line sample (H) by the wild-type control 
sample (W).  The resulting ratios calculated from each side of 
the equation should be approximately the same.  Minor 
variations between biological replicates are to be expected, 
however if these two ratios differ significantly it suggests that 
experimental error has been introduced, such as the presence 
of co-isolated species that have affected the reporter ion 
abundances in at least one of the samples. 
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Figure 5. Reporter ion spectra for peptide SPACGSDSVVTK (LmxM.28.2510) from samples Red, Ox, H and W (clockwise from top left).  
The average of each group of replicates is denoted by the dashed lines, with the calculated standard deviation displayed by the surrounding 
colored box.  Quantitation ratios for each sample have been calculated from the replicate averages, where the blue group corresponds to the 
denominator (see Table 2).  Peaks that do not correspond to the iodoTMT reporter ions have been labeled in grey. 
Table 2. Quantitation ratios have been calculated for peptide SPACGSDSVVTK (LmxM.28.2510) from each sample. Where 
multiple MS/MS spectra have been acquired, the table displays the average quantitation ratio from all available reporter 
ion spectra.  The change in oxidation has been calculated using both equations from Equation 1. 
Accession Protein Peptide Sequence Red Ox W H 
Ox
Red
 
H
W
 
LmxM.28.2510 
acyl-CoA dehydrogenase, 
putative 
SPACGSDSVVTK 1.059 0.354 0.056 0.014 0.334 0.250 
 
Ox
Red
=
H
W
 
Equation 1.  The normalized change in oxidation can be 
calculated using samples Ox and Red (left) or samples H and W 
(right).  For the full equation, see Supplementary Information.  
Since protein concentration has been measured before 
iodoTMT labeling, all proteins (including those without 
cysteine) have been used to normalize sample concentrations 
in order to combine individually-labeled samples equally, and 
as a result the overall number of iodoTMT-labeled proteins 
can vary between samples.  The L. mexicana samples showed 
a significant variation between the number of proteins and 
peptides observed between the four samples, with the fully-
reduced sample identifying over 300 labeled proteins 
compared with the NEM-blocked sample, which identified 
less than 90.  This observation can be explained by the low 
percentage of oxidized cysteines noted for many of the 
identified proteins in the wild-type and H-line samples, with 
approximately 90% of proteins in each cell-line detected with 
an average redox state of less than 25%.  As a result, far fewer 
cysteine residues are available for iodoTMT-labeling in the 
NEM-blocked sample.  Any differences in protein oxidation 
and/or expression between the two cell-lines will also alter the 
number of cysteine residues available for iodoTMT-labeling, 
and therefore may affect the proteins observed in each sample.  
Overall, the four L. mexicana samples resulted in cysteine 
quantitation for 445 proteins, however only 20 proteins were 
common to all four samples.  Since each cysteine in a protein 
can exist in different redox states, it is important to investigate 
each one separately by calculating relative quantitation for 
individual peptides.  By only focusing on peptides that were 
detected and quantified in all four samples, the number of 
quantified proteins reduced from 20 to 11.  Where multiple 
spectral matches have been identified as corresponding to the 
same labeled cysteine(s), an average quantitation ratio has 
been calculated.  This included peptides observed with and 
without methionine oxidation, and peptides also observed with 
a missed cleavage.   
Two peptides detected in the L. mexicana samples have 
been selected in order to illustrate the benefits of this advanced 
multiplexing method.  Firstly, an observed peptide from a 
membrane-bound acid phosphatase precursor 
(LmxM.36.2570) was shown to decrease slightly (~10%) in 
terms of overall protein concentration as well as in oxidation 
levels between the wild-type and H-line samples, suggesting 
that the change in oxidation observed was as a result of 
decreased protein expression.  This can be confirmed by the 
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near-identical percentage oxidation levels in the wild-type and 
H-line samples, 11.8% and 11.2% respectively, as shown in 
Figure 4 and Table 1. 
By comparison, a peptide from acyl-CoA dehydrogenase 
(LmxM.28.2510) was not shown to vary with respect to 
overall protein expression, however the oxidation level was 
seen to decrease by approximately 65%.  This was confirmed 
by the changes in percentage oxidation from approximately 
5.6% to 1.4% between the wild-type and H-line cell-lines, as 
shown in Figure 5 and Table 2. 
Other observations included the detection of tryparedoxin 
peroxidase (LmxM.15.1040), an enzyme that was not seen to 
vary in terms of protein expression, but was shown to decrease 
in oxidation level in the H-line sample.  This supports 
previous studies showing that tryparedoxin peroxidase plays a 
key role in Leishmania virulence.
24, 27-31
  Out of the 11 L. 
mexicana proteins quantified using this method, 5 are known 
to be enzymes; two membrane-bound acid phosphatases 
(LmxM.36.2570 and LmxM.36.2590) that showed no 
variation with respect to oxidation levels between the two cell-
lines, while the remaining three enzymes showed decreased 
oxidation in the H-line samples.  Only one protein was shown 
to be up-regulated with respect to protein expression, a 
hypothetical protein (LmxM.04.0130), which was observed 
with a two-fold increase in concentration in the H-line but an 
unchanging percentage oxidation level of approximately 80% 
in both cell-lines.  Of the remaining proteins, only calreticulin 
(LmxM.30.2600) was shown to have an increase in percentage 
oxidation levels in the H-line samples.   
Two peptides from the same hypothetical protein 
(LmxM.26.1960) were observed with near-identical protein 
expression quantitation values, as expected, however each 
peptide was shown to have differing oxidation changes 
between the two cell-lines – one remained constant while the 
other decreased by 50%.  This observation demonstrates the 
importance of monitoring redox changes for individual 
peptides, since cysteine residues within the same protein can 
exist in different forms and the redox state of each may be 
affected independently.  
The full table of results is detailed in Supplementary 
Information (Table S-1).  The mass spectrometry proteomics 
data have been deposited to the ProteomeXchange Consortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE 
partner repository
32
 with the dataset identifier PXD010938. 
 
CONCLUSIONS 
This study clearly demonstrates the advantages of using 
iodoTMT multiplexing to directly relate redox state with 
change in protein expression for complex proteomic samples, 
providing more depth and information from a single set of 
samples.  The application of this multi-quantitation method to 
samples originating from a single source allows 
inconsistencies in growth conditions and sample variability to 
be minimized. The results acquired have not only 
demonstrated the practicality of this method, but have also 
provided a list of proteins that have shown significant 
oxidation changes between virulent and attenuated Leishmania 
mexicana, and will be the focus for further study.   
The variation in the number of iodoTMT-labeled proteins 
between each cell-line means that quantitation channel 
normalization cannot be performed during data processing and 
therefore minor discrepancies in protein concentration 
between replicates cannot be corrected for.  Previous studies 
have also noted a slight shift in reporter ion signal accuracies 
at low signal-to-noise ratios, which may have an adverse effect 
on the resulting quantitation ratios.
22
   
Given the relationship between the four samples, as 
described in Equation 1, it is possible to extrapolate a missing 
quantitation value if a peptide is observed in only three out of 
the four samples.  This may be particular useful when 
considering samples with a low percentage of oxidized 
cysteines, where the number of iodoTMT-labeled peptides in 
the NEM-blocked sample will be significantly less than the 
other samples.  In this dataset, an additional 52 proteins can be 
identified and quantified from peptides observed in any three 
out of the four samples.  Improved proteomic coverage, which 
might be achieved by sample fractionation and/or through 
multidimensional chromatography, could result in improved 
data on both protein expression and redox state, enabling more 
proteins to be assessed and represented in all replicates. 
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